Top

European Journal of Medical Research

Published in:

Open Access 01-12-2024 | Parathyroidectomy | Research

A nomogram prediction model for hungry bone syndrome in dialysis patients with secondary hyperparathyroidism after total parathyroidectomy

Authors: Dan Gao, Yali Liu, Wenpeng Cui, Xuehong Lu, Yan Lou

Published in: European Journal of Medical Research | Issue 1/2024

Abstract

Objective

Secondary hyperparathyroidism (SHPT) is a common complication of chronic kidney disease (CKD). Hungry bone syndrome (HBS) after parathyroidectomy (PTX) is a serious complication, which can lead to diarrhea, convulsion, arrhythmia and even death. This study was aimed to determine the risk factors for HBS after PTX in dialysis patients with SHPT and construct a nomogram prediction model to predict the incidence of postoperative complications.

Methods

Clinical data were collected from 80 maintenance hemodialysis (MHD) patients with SHPT who received total PTX in the Second Hospital of Jilin University from January 2018 to September 2021. In line with the inclusion and exclusion criteria, totally 75 patients were finally enrolled for analysis. Patients were divided into two groups for retrospective analysis according to the severity of postoperative HBS, including HBS group and non-HBS (N-HBS) group. Univariate and multivariate logistic regression analyses were conducted to determine the risk factors for postoperative HBS. Afterwards, the receiver operating characteristic (ROC) curves were plotted based on the statistical analysis results, aiming to compare the prediction effects of different predicting factors. Finally, the nomogram was established to evaluate the occurrence probability of postoperative complications predicted by the risk factors.

Results

Among the 75 patients, 32 had HBS (HBS group), while 43 did not have HBS (N-HBS group). Univariate analysis results indicated that, the preoperative intact parathyroid hormone (iPTH) and serum alkaline phosphatase (ALP) levels in HBS group were significantly higher than those in N-HBS group, while preoperative hemoglobin and preoperative albumin (Alb) levels were significantly lower than those in N-HBS group. As discovered by multivariate logistic regression analysis, preoperative iPTH (OR = 1.111, P = 0.029) and ALP (OR = 1.010, P < 0.001) were the independent risk factors for postoperative HBS. ROC curve analysis suggested that the area under the curve (AUC) values of these two indicators were 0.873 and 0.926, respectively (P < 0.0001). Subsequently, the nomogram model for predicting HBS was constructed. The model verification results indicated that the predicted values were basically consistent with the measured values, with the C-index of 0.943 (95% CI 0.892–0.994). Besides, the calibration curve was consistent with the ideal curve, demonstrating the favorable accuracy and discrimination of the model.

Conclusions

Preoperative iPTH and preoperative ALP are the risk factors for postoperative HBS, which can be used to guide the early clinical intervention.

Liu J, Huang Q, Yang M, Huang L, Zhang L. Risk factors predicting severe hypocalcemia after total parathyroidectomy without autotransplantation in patients with secondary hyperparathyroidism. J Int Med Res. 2020;48(1): 300060519897505. https://doi.org/10.1177/0300060519897505.CrossRefPubMed

Wen P, Xu L, Zhao S, Gan W, Hou D, Zhang L, Cao J, Xiong M, Jiang L, Yang J. Risk factors for severe hypocalcemia in patients with secondary hyperparathyroidism after total parathyroidectomy. Int J Endocrinol. 2021;2021: 6613659. https://doi.org/10.1155/2021/6613659.CrossRefPubMedPubMedCentral

Wong J, Fu WH, Lim ELA, Ng CFJ, Choong HL. Hungry bone syndrome after parathyroidectomy in end-stage renal disease patients: review of an alkaline phosphatase-based treatment protocol. Int Urol Nephrol. 2020;52(3):557–64. https://doi.org/10.1007/s11255-020-02387-0.CrossRefPubMed

Tan PG, Ab Hadi IS, Zahari Z, Yahya MM, Wan Zain WZ, Wong MP, Ramely R, Md Hashim MN, Syed Abd Aziz SH, Zakaria Z, Zakaria AD. Predictors of early postoperative hypocalcemia after total parathyroidectomy in renal hyperparathyroidism. Ann Surg Treat Res. 2020;98(1):1–6. https://doi.org/10.4174/astr.2020.98.1.1.CrossRefPubMed

Palmer SC, Nistor I, Craig JC, Pellegrini F, Messa P, Tonelli M, Covic A, Strippoli GF. Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials. PLoS Med. 2013;10(4): e1001436. https://doi.org/10.1371/journal.pmed.1001436.CrossRefPubMedPubMedCentral

Wei Y, Yu MA, Qian LX, Zhao ZL, Cao XJ, Peng LL, Li Y. Hypocalcemia after ultrasound-guided microwave ablation and total parathyroidectomy for secondary hyperparathyroidism: a retrospective study. Int J Hyperthermia. 2020;37(1):819–25. https://doi.org/10.1080/02656736.2020.1785557.CrossRefPubMed

Moldovan D, Racasan S, Kacso IM, Rusu C, Potra A, Bondor C, Patiu IM, Gherman-Caprioara M. Survival after parathyroidectomy in chronic hemodialysis patients with severe secondary hyperparathyroidism. Int Urol Nephrol. 2015;47(11):1871–7. https://doi.org/10.1007/s11255-015-1106-x.CrossRefPubMed

Cartwright C, Anastasopoulou C. Hungry bone syndrome. Treasure Island (FL): StatPearls; 2021.

Ding Y, Wang H, Zou Q, Jin Y, Zhang Z, Huang J. Factors associated with calcium requirements after parathyroidectomy in chronic kidney disease patients. Int Urol Nephrol. 2018;50(3):535–40. https://doi.org/10.1007/s11255-017-1759-8.CrossRefPubMed

10.

Kang BH, Hwang SY, Kim JY, Hong YA, Jung MY, Lee EA, Lee JE, Lee JB, Ko GJ, Pyo HJ, Kwon YJ. Predicting postoperative total calcium requirements after parathyroidectomy in secondary hyperparathyroidism. Korean J Intern Med. 2015;30(6):856–64. https://doi.org/10.3904/kjim.2015.30.6.856.CrossRefPubMedPubMedCentral

11.

Goh BL, Yudisthra MG, Hisham AN. Alkaline phosphatase predicts calcium requirements after total parathyroidectomy in patients receiving dialysis. Br J Surg. 2010;97(2):185–8. https://doi.org/10.1002/bjs.6818.CrossRefPubMed

12.

Loke SC, Kanesvaran R, Yahya R, Fisal L, Wong TW, Loong YY. Efficacy of an intravenous calcium gluconate infusion in controlling serum calcium after parathyroidectomy for secondary hyperparathyroidism. Ann Acad Med Singap. 2009;38(12):1074–80.CrossRefPubMed

13.

Ge P, Liu S, Sheng X, Li S, Xu M, Jiang J, Chen S. Serum parathyroid hormone and alkaline phosphatase as predictors of calcium requirements after total parathyroidectomy for hypocalcemia in secondary hyperparathyroidism. Head Neck. 2018;40(2):324–9. https://doi.org/10.1002/hed.24965.CrossRefPubMed

14.

Chen P, Satterwhite JH, Licata AA, Lewiecki EM, Sipos AA, Misurski DM, Wagman RB. Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis. J Bone Miner Res. 2005;20(6):962–70. https://doi.org/10.1359/JBMR.050105.CrossRefPubMed

15.

Muppidi V, Meegada SR, Rehman A. Secondary hyperparathyroidism. Treasure Island (FL): StatPearls; 2021.

16.

National Kidney F. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(4 Suppl 3):S1-201.

17.

Yang G, Zha X, Mao H, Yu X, Wang N, Xing C. Hypocalcemia-based prediction of hungry bone syndrome after parathyroidectomy in hemodialysis patients with refractory secondary hyperparathyroidism. J Int Med Res. 2018;46(12):4985–94. https://doi.org/10.1177/0300060518788744.CrossRefPubMedPubMedCentral

18.

Silva BC, Bilezikian JP. Parathyroid hormone: anabolic and catabolic actions on the skeleton. Curr Opin Pharmacol. 2015;22:41–50. https://doi.org/10.1016/j.coph.2015.03.005.CrossRefPubMedPubMedCentral

19.

Cheng SP, Liu CL, Chen HH, Lee JJ, Liu TP, Yang TL. Prolonged hospital stay after parathyroidectomy for secondary hyperparathyroidism. World J Surg. 2009;33(1):72–9. https://doi.org/10.1007/s00268-008-9787-2.CrossRefPubMed

20.

Yajima A, Ogawa Y, Takahashi HE, Tominaga Y, Inou T, Otsubo O. Changes of bone remodeling immediately after parathyroidectomy for secondary hyperparathyroidism. Am J Kidney Dis. 2003;42(4):729–38. https://doi.org/10.1016/s0272-6386(03)00909-0.CrossRefPubMed

21.

Liu S, Zhu W, Li S, Cui T, Li Z, Zhang B, Li Z, Wu J, Liang X, Lin Z, Shi W. The effect of bovine parathyroid hormone withdrawal on MC3T3-E1 cell proliferation and phosphorus metabolism. PLoS ONE. 2015;10(3): e0120402. https://doi.org/10.1371/journal.pone.0120402.CrossRefPubMedPubMedCentral

22.

Kaya C, Tam AA, Dirikoc A, Kilicyazgan A, Kilic M, Turkolmez S, Ersoy R, Cakir B. Hypocalcemia development in patients operated for primary hyperparathyroidism: Can it be predicted preoperatively? Arch Endocrinol Metab. 2016;60(5):465–71. https://doi.org/10.1590/2359-3997000000207.CrossRefPubMedPubMedCentral

23.

Lu KC, Ma WY, Yu JC, Wu CC, Chu P. Bone turnover markers predict changes in bone mineral density after parathyroidectomy in patients with renal hyperparathyroidism. Clin Endocrinol (Oxf). 2012;76(5):634–42. https://doi.org/10.1111/j.1365-2265.2011.04265.x.CrossRefPubMed

24.

Urena P, De Vernejoul MC. Circulating biochemical markers of bone remodeling in uremic patients. Kidney Int. 1999;55(6):2141–56. https://doi.org/10.1046/j.1523-1755.1999.00461.x.CrossRefPubMed

25.

Schneider R, Steinmetz C, Karakas E, Bartsch DK, Schlosser K. Influence of parathyroidectomy on bone metabolism and bone pain in patients with secondary hyperparathyroidism. Eur Surg Res. 2018;59(1–2):35–47. https://doi.org/10.1159/000486172.CrossRefPubMed

26.

Siqueira FR, Oliveira KC, Dominguez WV, Truyts CAM, Moyses RMA, Dos Reis LM, Jorgetti V. Effect of parathyroidectomy on bone tissue biomarkers and body composition in patients with chronic kidney disease and secondary hyperparathyroidism. Eur J Clin Nutr. 2021;75(7):1126–33. https://doi.org/10.1038/s41430-020-00829-7.CrossRefPubMed

27.

Yang M, Zhang L, Huang L, Sun X, Ji H, Lu Y. Risk factors for elevated preoperative alkaline phosphatase in patients with refractory secondary hyperparathyroidism. Am Surg. 2017;83(12):1368–72.CrossRefPubMed

28.

Brasier AR, Nussbaum SR. Hungry bone syndrome: clinical and biochemical predictors of its occurrence after parathyroid surgery. Am J Med. 1988;84(4):654–60. https://doi.org/10.1016/0002-9343(88)90100-3.CrossRefPubMed

29.

Guo CY, Holland PA, Jackson BF, Hannon RA, Rogers A, Harrison BJ, Eastell R. Immediate changes in biochemical markers of bone turnover and circulating interleukin-6 after parathyroidectomy for primary hyperparathyroidism. Eur J Endocrinol. 2000;142(5):451–9. https://doi.org/10.1530/eje.0.1420451.CrossRefPubMed

30.

Sun L, He X, Liu T. Preoperative serum alkaline phosphatase: a predictive factor for early hypocalcaemia following parathyroidectomy of primary hyperparathyroidism. Chin Med J (Engl). 2014;127(18):3259–64.CrossRefPubMed

31.

Kaderli RM, Riss P, Dunkler D, Pietschmann P, Selberherr A, Scheuba C, Niederle B. The impact of vitamin D status on hungry bone syndrome after surgery for primary hyperparathyroidism. Eur J Endocrinol. 2018;178(1):1–9. https://doi.org/10.1530/EJE-17-0416.CrossRefPubMed

32.

Ko WC, Liu CL, Lee JJ, Liu TP, Wu CJ, Cheng SP. Osteocalcin is an independent predictor for hungry bone syndrome after parathyroidectomy. World J Surg. 2020;44(3):795–802. https://doi.org/10.1007/s00268-019-05251-0.CrossRefPubMed

Title: A nomogram prediction model for hungry bone syndrome in dialysis patients with secondary hyperparathyroidism after total parathyroidectomy
Authors: Dan Gao
Yali Liu
Wenpeng Cui
Xuehong Lu
Yan Lou
Publication date: 01-12-2024
Publisher: BioMed Central
Keywords: Parathyroidectomy
Parathyroidectomy
Hyperparathyroidism
Published in: European Journal of Medical Research / Issue 1/2024
Electronic ISSN: 2047-783X
DOI: https://doi.org/10.1186/s40001-024-01801-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

A nomogram prediction model for hungry bone syndrome in dialysis patients with secondary hyperparathyroidism after total parathyroidectomy

Abstract

Objective

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2024

Multi-omics and immunogenomics analysis revealed PFKFB3 as a targetable hallmark and mediates sunitinib resistance in papillary renal cell carcinoma: in silico study with laboratory verification

A review of the current status and progress in difficult airway assessment research

The synthetic cannabinoids menace: a review of health risks and toxicity

Changes of Mycobacterium tuberculosis specific antigen-stimulated CD27−CD38+IFN-γ+CD4+ T cells before and after anti-tuberculosis treatment

The predictive value of neurally adjusted ventilatory assist indexes for the prognosis of patients with severe cerebral hemorrhage

The efficacy and safety of cannabidiol (CBD) in pediatric patients with Dravet Syndrome: a narrative review of clinical trials